CAR T-cell Therapy in Patients With Renal Dysfunction
Status:
Not yet recruiting
Trial end date:
2026-08-31
Target enrollment:
Participant gender:
Summary
This is a prospective, descriptive study designed to assess the feasibility of administering
CAR T therapy among patients with moderate to severe renal impairment using dose adjusted
lymphodepleting chemotherapy.